/
/
/

Asston Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--38%61%
--239%218%
---5%
42%42%52%51%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
LUPIN-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
APL-MT
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,904₹463791 Cr38.3412.0762.82₹11479 Cr
9,245₹245081 Cr83.7934.04128.41₹2568 Cr
4,924.7₹190351 Cr87.2816.7297.06₹2163 Cr
1,135₹114833 Cr25.449.4262.53₹5040 Cr
1,389₹114163 Cr33.879.7757.87₹3879 Cr
1,872.15₹100660 Cr92.066.829.25₹889 Cr
2,135₹98431 Cr17.830.95154.36₹5333 Cr
2,345₹98305 Cr48.1313.7571.08₹1913 Cr
1,155₹96906 Cr30.075.3263.99₹4196 Cr
1,627₹95300 Cr25.6717.9596.84₹3505 Cr
106.9₹92 Cr23.834.92₹4 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022
₹6 Cr₹78 L₹70 L₹70 L
₹4 Cr₹6 Cr₹1 Cr₹23 L
₹4 Cr₹6 Cr₹1 Cr₹23 L
₹11 Cr₹6 Cr₹2 Cr₹93 L
₹14 L₹91 L₹97 L₹69 L
₹2 Cr₹72 L₹85 L₹25 L
-₹2 L₹2 L₹3 L₹2 L
₹16 L₹16 L₹7 L₹5 L
₹2 Cr₹2 Cr₹2 Cr₹1 Cr
₹6 Cr₹6 Cr₹6 Cr₹5 Cr
₹3 Cr₹83 L₹45 L₹51 L
₹4 Cr₹5 Cr₹3 Cr₹2 Cr
₹2 Cr₹86 L₹67 L₹20 L
₹15 Cr₹12 Cr₹10 Cr₹8 Cr
₹28 Cr₹20 Cr₹14 Cr₹9 Cr
₹7 Cr₹7 Cr₹5 Cr₹3 Cr
₹1 Cr₹1 Cr₹1 Cr₹94 L
₹14 L₹11 L₹6 L₹3 L
₹96 L₹1 Cr₹1 Cr₹92 L
₹13 L₹13 L₹1 Cr₹1 Cr
₹0₹71 L₹67 L₹0
₹1 Cr₹2 Cr₹3 Cr₹2 Cr
₹72 L₹1 Cr₹2 Cr₹50 L
₹25 Cr₹16 Cr₹9 Cr₹6 Cr
₹20 L₹64,000₹12 L₹14 L
₹1 L₹0₹0₹0
₹2 Cr₹74 L₹46 L₹34 L
₹27 Cr₹18 Cr₹11 Cr₹7 Cr
₹12 Cr₹6 Cr₹91 L-₹18 L
₹28 Cr₹20 Cr₹14 Cr₹9 Cr
₹17₹82₹28₹13
₹17₹10₹4₹2

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022
₹6 Cr₹2 Cr₹1 Cr₹16 L
₹93 L₹94 L₹75 L₹44 L
-₹7 Cr-₹6 Cr-₹2 Cr-₹2 Cr
-₹17 L-₹3 Cr-₹30 L-₹1 Cr
-₹16 L-₹4 Cr-₹32 L-₹1 Cr
₹87 L-₹54,000-₹91 L-₹20,000
-₹51 L₹4 Cr₹1 Cr₹1 Cr
₹19 L-₹12 L-₹1 L₹10 L
₹63,000₹12 L₹14 L₹3 L
₹20 L₹64,000₹12 L₹14 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)106.00
Volume (₹)45,000.00
High (₹)110.00
Upper Circuit113.55
Low (₹)103.00
Lower Circuit102.75
Prev Close108.15
52W High (₹)126.10
Price106.90
52W Low (₹)60.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)92.06 Cr
Div. Yield (%)0.00
PE Ratio23.83
Debt to Equity0.68
Price to Book0.00
Book Value17.09
EPS (TTM)4.54
Face Value10.00
ROE (%)50.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
APL-MTNSE
LTP
1W Low
1W High
Market cap (₹)
1904-16.1 (-0.84%)
1901
1964.85
4,63,791Cr
9245-24 (-0.26%)
9051.85
9296
2,45,081Cr
4924.7-110.3 (-2.19%)
4890
5049
1,90,351Cr
1135-52 (-4.38%)
1130.75
1191.45
1,14,833Cr
1389-29 (-2.05%)
1388.50
1426.20
1,14,163Cr
1872.15-63.15 (-3.26%)
1812
1947.90
1,00,660Cr
2135-40 (-1.84%)
2135
2209
98,431Cr
2345-42.4 (-1.78%)
2323.15
2407.40
98,305Cr
1155-22.8 (-1.94%)
1155
1179.90
96,906Cr
1627-23 (-1.39%)
1627
1706.70
95,300Cr
106.9-9 (-7.77%)
103
126.10
92Cr

Asston Pharmaceuticals Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Asston Pharmaceuticals Ltd Quaterly Results Key Takeaways